| abstract |
Described are new compounds of formula (I), pharmaceutically acceptable salts of these compounds, and pharmaceutical compositions containing these compounds, which are modulators of the liver X-receptor and can be used to treat diseases and disorders associated with the liver's X-receptor. Methods of using new compounds of formula (I) and pharmaceutical compositions containing these compounds for the treatment of atherosclerosis, cardiovascular disease, Alzheimer's disease, dermatitis, dyslipidemia, cancer and other diseases or disorders are also proposed. |